Global Fund, United States Agency for International Development (USAID) and Stop TB Partnership have entered into a collaboration with Goa-based Molbio Diagnostics, inventor of the globally renowned Truenat platform.
The collaboration will enable countries to procure the WHO endorsed Truenat platform at internationally negotiated prices, making the technology more accessible and affordable across the world.
The collaborative partnership is a crucial move in the global fight to end tuberculosis (TB) by 2030. The move enables high-quality rapid TB testing - one of the largest shortfalls in the global TB response - in all nations supported by the Global Fund, USAID, and the Stop TB Partnership.
The National Tuberculosis Elimination Programme has already deployed Truenat in over 3500 primary/community health centres (PHCs/CHCs) across all states in India. The international collaboration will now provide an opportunity for other countries to adopt this Indian technology under their respective national TB programmes, for global impact.
